AllianceBernstein’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

AllianceBernstein’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,737	Closed	-$607K	–	3233
2024 Q4	$607K	Buy	+6,737	New	+$653K	﹤0.01%	2547
2024 Q2	–	Sell	-12,720	Closed	-$1.21M	–	3301
2024 Q1	$1.21M	Sell	12,720 -40,231	-76%	-$3.73M	﹤0.01%	2158
2023 Q4	$4.73M	Buy	+52,951	New	+$3.93M	﹤0.01%	1519
2021 Q2	–	Sell	-3,763	Closed	-$510K	–	3419
2021 Q1	$510K	Buy	+3,763	New	+$563K	﹤0.01%	2652
2019 Q1	–	Sell	-6,044	Closed	-$434K	–	3141
2018 Q4	$434K	Sell	6,044 -814,792	-99%	-$65.6M	﹤0.01%	2543
2018 Q3	$78.7M	Sell	820,836 -402,200	-33%	-$39M	0.05%	376
2018 Q2	$116M	Buy	1,223,036 +134,407	+12%	+$12.4M	0.08%	254
2018 Q1	$95.5M	Buy	1,088,629 +199,165	+22%	+$18.2M	0.07%	300
2017 Q4	$75.5M	Buy	+889,464	New	+$74.5M	0.05%	387
2014 Q2	–	Sell	-2,103	Closed	-$100K	–	3651
2014 Q1	$100K	Buy	+2,103	New	+$108K	﹤0.01%	2972

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

AllianceBernstein's XBI Position: Q1 2025 in Review

AllianceBernstein sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 6,737 shares — an estimated $607K sold.

AllianceBernstein first reported a position in XBI in Q1 2014 and held it in 10 quarters. The position peaked at $116M in Q2 2018. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

AllianceBernstein reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
AllianceBernstein sold 6,737 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $607K.
AllianceBernstein first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and held it in 10 quarters.
AllianceBernstein's State Street SPDR S&P Biotech ETF position peaked at $116M in Q2 2018.
685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on AllianceBernstein's 13F filing for Q1 2025, filed 15 May 2025.